Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil

被引：1

作者：

Auriacombe, S ^{[1
]}

Pere, JJ ^{[1
]}

机构：

[1] Clin St Augustin, Bordeaux, France

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2002年 / 18卷 / 06期

关键词：

D O I：

10.1185/030079902125000958

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：IV / VI

页数：3

共 50 条

[1] Comments on efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
McRae, TD
Schwam, EM
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : I - III
[2] Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
Auriacombe, S
Pere, JJ
Loria-Kanza, Y
Vellas, B
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (03) : 129 - 138
[3] Rivastigmine may benefit patients with Alzheimer's disease (AD) who have failed to benefit from previous donepezil treatment
Grossberg, G
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 262 - 262
[4] No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment
Auriacombe, S
Pere, JJ
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 715 - 717
[5] Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease
Bullock, R
Bergman, H
Touchon, J
Gambina, G
He, YS
Nagel, J
Lane, R
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) : 483 - 494
[6] Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine
Kurz, AF
Gold, M
[J]. NEUROBIOLOGY OF AGING, 2004, 25 : S202 - S203
[7] Metaanalysis of randomized trials of the efficacy and safety of Donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease
Ritchie, CW
Ames, D
Clayton, T
Lai, R
[J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (04): : 358 - 369
[8] Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
Hansen, Richard A.
Gartlehner, Gerald
Webb, Aaron P.
Morgan, Laura C.
Moore, Charity G.
Jonas, Daniel E.
[J]. CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 211 - 225
[9] Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients
Zhang, Nan
Gordon, Marc L.
[J]. CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 1963 - 1970
[10] Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
Dantoine, T
Auriacombe, S
Sarazin, M
Becker, H
Pere, JJ
Bourdeix, I
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 110 - 118

← 1 2 3 4 5 →